Stock Updates

Today’s Top Gainers in the Market Zoetis Inc. (NYSE:ZTS) from Healthcare

Today’s top gainers include the company Zoetis Inc. (NYSE:ZTS) which is in the industry Drugs – Generic, gaining 1.62% today. In the last week its performance is 0.63%, and 7.82% for the past quarter. Currently, Zoetis Inc., ZTS has a target price of 55.15, so today’s gain of 1.62% is a significant step towards its target price. The GAP today is therefore 0.29%.

Zoetis Inc. (NYSE:ZTS), has a market cap of 26150.05, and is based in USA. Insider ownership is at 0.01%, and institutional ownership is 95.00%.

At the current price of 52.69, it has a dividend yield of 0.72%, and its target price is 55.15. This is with a profit margin of 13.20%, and total debt/equity of 3.29. Zoetis Inc. (NYSE:ZTS) has a P/E of 41.16, as well as a forward P/E of 22.66.

With a current EPS of 1.28, and a forecasted EPS growth for next year at 21.92%,Zoetis Inc. (NYSE:ZTS) has had a EPS growth for the past five years at 29.30%. For the next five years EPS growth is projected to be 12.88%.

Performance for the year is 24.13%. Since its IPO date on 2/1/2013, the total performance to date is 10.66%.

Volume today for Zoetis Inc. (NYSE:ZTS), is 3118800, while its average volume is 3235.39. Whilst the total gain today was 1.62%, it did have a day high of 0.09%.

Volatility for this week has been at 1.44%, and 1.43% for the month. The 52-week low for Zoetis Inc., ZTS has been 38.29%, while the 52-week-high has reached 0.09%.

Looking at its return of investments, which is 5.70%, and its return on assets is 8.60%. Zoetis Inc. (NYSE:ZTS) has an operating margin of 20.70%. With a sales growth of 2.80% quarter over quarter. Bearing in mind that Zoetis Inc., ZTS is in the sector Healthcare, its long-term debt/equity is 3.29, and has a current ratio of 3.2 and 1.7 for quick ratio.

So what is the value of Zoetis Inc.? Well its PEG is 3.2, and the P/S is 5.38, along with a P/B of 19.3. Meanwhile it has a p/cash of 39.74.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Peter Clarke

Leave a Comment